Accuracy of erythrogram and serum ferritin for the maternal anemia diagnosis (AMA): a phase 3 diagnostic study on prediction of the therapeutic responsiveness to oral iron in pregnancy

BMC Pregnancy and Childbirth

Malaquias Batista-Filho⁵  Debora Bresani Salvi¹  Carlos Eduardo Lopes Tavares-de-Melo²  Daniel Falcão Felisberto²  Maria Cynthia Braga⁴  Cristiane Campello Bresani³ 

[1] Nutrition Research Group at Instituto de Medicina Integral Prof Fernando Figueira – IMIP, Rua dos Coelhos, 300, Boa Vista, Recife, PE CEP: 50.070-550, Brazil;Faculdade Pernambucana de Saúde – FPS, Av. Jean Emile Favre, 422 Imbiribeira, Recife, PE CEP: 51.200-060, Brazil;Instituto Nacional do Seguro Social/Ministério da Previdência Social – INSS/MPS, Av Jorn Mário Melo, 343, Santo Amaro, Recife, PE CEP: 50.040-010, Brazil;Postgraduate Program in Public Health at Centro de Pesquisas Aggeu Magalhães – Fundação Oswaldo Cruz – CPQAM/FIOCRUZ, Av. Professor Moraes Rego, s/n - Campus da UFPE - Cidade Universitária, Recife, PE CEP: 50.670-420, Brazil;Postgraduate Program in Maternal and Child Health of IMIP, Rua dos Coelhos, 300, Boa Vista, Recife, PE CEP: 50.070-550, Brazil

关键词: Ferrous sulfate;    Patient compliance;    Adverse effects;    Specificity;    Sensitivity;    Ferritins;    Erythrocyte indices;    Pregnancy;    Diagnosis;    Iron-deficiency;    Anemia;   

Others  :  1151210
DOI  :  10.1186/1471-2393-13-13

 received in 2012-12-13, accepted in 2013-01-08,  发布年份 2013

【 摘 要 】

Background

Pregnancy anemia remains as a public health problem, since the official reports in the 70’s. To guide the treatment of iron-deficiency anemia in pregnancy, the haemoglobin concentration is the most used test in spite of its low accuracy, and serum ferritin is the most reliable test, although its cutoff point remains an issue.

Methods/design

The aim of this protocol is to verify the accuracy of erythrocyte indices and serum ferritin (studied tests) for the diagnosis of functional iron-deficiency in pregnancy using the iron-therapy responsiveness as the gold-standard. This is an ongoing phase III accuracy study initiated in August 2011 and to be concluded in April 2013. The subjects are anemic pregnant women (haemoglobin concentration < 11.0 g/dL) attended at a low-risk prenatal care center in the Northeast of Brazil. The sample size (n 278) was calculated to estimate sensitivity of 90% and 80% of specificity with relative error of 10% and power of 95%. This study has a prospective design with a before-after intervention of 80 mg of daily oral iron during 90 days and will be analyzed as a delayed-type cross-sectional study. Women at the second trimester of pregnancy are being evaluated with clinical and laboratorial examinations at the enrollment and monthly. The ‘responsiveness to therapeutic test with oral iron’ (gold-standard) was defined to an increase of at least 0.55 Z-score in haemoglobin after 4 weeks of treatment and a total dose of 1200 mg of iron. At the study conclusion, sensitivities, specificities, predictive values, likelihood ratios and areas under the ROC (Receiver Operating Characteristic) curves of serum ferritin and erythrocyte indices (red blood cell count, haematocrit, haemoglobin concentration, mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, red blood cell distribution width, reticulocyte count) will be tested. The compliance and adverse effects are considered confounding variables, since they are the main obstacles for the iron-therapy responsiveness.

Discussion

This study protocol shows a new approach on iron-deficiency anemia in pregnancy from a functional point of view that could bring some insights about the diagnostic misclassifications arising from the dynamic physiologic changes during the gestational cycle.

Trial registration

WHO International Clinical Trials Registry Platform U1111-1123-2605.

【 授权许可】

   
2013 Bresani et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]World Health Organization: Iron deficiency anemia: assessment, prevention and control – a guide for program managers. Geneva, Switzerland: WHO; 2001.
• [2]World Health Organization: Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. Geneva, Switzerland: WHO; 2008.
• [3]Murphy JF, O’Riordan J, Newcombe RG, Coles EC, Pearson JF: Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet 1986, 1:992-995.
• [4]Steer P, Alam MA, Wadsworth J, Welch A: Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. Br Med J 1995, 310:489-491.
• [5]Allen LH: Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000, 71(Suppl):1280-1284.
• [6]Scholl TO, Reilly T: Anemia, iron and pregnancy outcome. J Nutr 2000, 130:443.
• [7]Yip R: Significance of an abnormally low or high haemoglobin concentration during pregnancy: special consideration of iron nutrition. Am J Clin Nutr 2000, 72(Suppl):272-279.
• [8]Rasmussen KM: Iron deficiency anemia: reexamining the nature and magnitude of the public health problem. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality? J Nutr 2001, 131(Suppl):590-603.
• [9]Stoltzfus RJ: Iron deficiency: global prevalence and consequences. Food Nutr Bull 2003, 24(Suppl 4):99-103.
• [10]World Health Organization: Control of nutritional anaemia with special reference to iron deficiency. Technical Report Series no. 580. Geneva, Switzerland: WHO; 1975.
• [11]United Nations Children’s Fund/World Health Organization: Prevention and control of iron deficiency anaemia in women and children. Geneva, Switzerland: UNICEF/WHO; 1999.
• [12]Hyder SM, Persson LA, Chowdhury AM, Ekström EC: Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy. J Health Popul Nutr 2002, 20:175-179.
• [13]Ekström ECM, Kavishe FP, Habicht JP, Frongillo EA Jr, Rasmussen KM, Hemed L: Adherence to iron supplementation during pregnancy in Tanzania: determinants and hematologic consequences. Am J Clin Nutr 1996, 64:368-374.
• [14]Ekström EC, Hyder SM, Chowdhury AM, Chowdhury SA, Lönnerdal B, Habicht JP, Persson LA: Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: disentangling the issues. Am J Clin Nutr 2002, 76:1392-1400.
• [15]Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM: Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Nutr 2003, 78:145-153.
• [16]Kumar A, Jain S, Singh NP, Singh T: Oral versus high dose parenteral iron supplementation in pregnancy. Int J Ginecol Obstet 2005, 89:7-13.
• [17]Saha L, Pandhi P, Gopalan S, Malhotra S, Saha PK: Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anaemia in pregnant women. Med Gen Med 2007, 9:1.
• [18]Zhou SJ, Gibson RA, Crowther CA, Makrides M: Should we lower the dose of iron when treating anaemia in pregnancy? A randomized dose–response trial. Eur J Clin Nutr 2009, 63:183-190.
• [19]Reveiz L, Gyte GML, Cuervo LG, Casasbuenas A: Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews. [The Cochrane Library] Issue 11, Art. No. CD003094
• [20]Peña-Rosas JP, De-Regil LM, Dowswell T, Viteri FE: Intermittent oral iron supplementation during pregnancy. [The Cochrane Library] Issue 11, Art. No. CD009997
• [21]Centers for Disease Control and Prevention: Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 1998, 47((RR-3):1-36.
• [22]Centers for Disease Control and Prevention: Iron Deficiency - United States, 1999–2000. MMWR Recomm Rep 2002, 51(40):897-899.
• [23]Sackett DL, Haynes RB: The architecture of diagnostic research. In The evidence base of clinical diagnosis. Edited by Knottnerus JA. London: BMJ books; 2002:19-37.
• [24]Puolakka J, Jänne O, Pakarinen A, Vihko R: Serum ferritin in the diagnosis of anemia during pregnancy. Acta Obstet Gynecol Scand 1980, 95(Suppl):57-63.
• [25]Thompson WG: Comparison of tests for diagnosis of iron depletion in pregnancy. Am J Obstet Gynecol 1988, 159:1132-1134.
• [26]Volpi E, De Grandis T, Alba E, Mangione M, Dall’Amico D, Bollati C: Variations in ferritin levels in blood during physiological pregnancy. Minerva Ginecol 1991, 43:387-391.
• [27]van den Broek NR, Letsky EA, Shenkin A: Iron status in pregnant women: which measurements are valid? Br J Haematol 1998, 103:817-824.
• [28]Tam KF, Lao TT: Haemoglobin and red cell indices correlated with serum ferritin concentration in late pregnancy. Obstet Gynecol 1999, 93:427-431.
• [29]Casanova BF, Sammel MD, Macones GA: Development of a clinical prediction rule for iron deficiency anemia in pregnancy. Am J Obstet Gynecol 2005, 193:460-466.
• [30]Petraglia B, da Silva LGP, de Rezende Filho J, Netto HC, Montenegro CAB: Avaliação dos valores eritrocitários no ciclo grávido-puerperal. J Bras Ginecol 1994, 1014:139-144.
• [31]van Buul EJ, Steegers EA, Jongsma HW, Eskes TK, Thomas CM, Hein PR: Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study. Neth J Med 1995, 46:73-85.
• [32]Milman N, Byg KE, Agger AO: Haemoglobin and erythrocyte indices during normal pregnancy and postpartum in 206 women with and without iron supplementation. Acta Obstet Gynecol Scand 2000, 79:89-98.
• [33]Beaton GH, McCabe GP: Efficacy of intermittent iron supplementation in the control of iron deficiency anemia in developing countries - an analysis of experience: final report to the Micronutrient Initiative (MI). Canada, Toronto: MI/Canadian International Development Agency (CIDA); 1999.
• [34]Milman N: Iron and pregnancy – a delicate balance. Ann Hematol 2006, 85:559-565.
• [35]Bresani CC, Souza AI, Batista Filho M, Figueirôa JN: Anemia and iron deficiency in pregnant women: disagreements among the results of a cross-sectional study. Brazilian Journal of Mother and Child Health 2007, 7(Suppl 1):15-22.
• [36]Knottnerus JA, Muris JW: Assessment of the accuracy of diagnostic tests: the cross-sectional study. In The evidence base of clinical diagnosis. London: BMJ books; 2002:39-59.
• [37]Beaton GH: Iron needs during pregnancy: do we need to rethink our targets? Am J Clin Nutr 2000, 72(Suppl):265-271.
• [38]Souza AI, Batista Filho M, Bresani CC, Ferreira LOC, Figueirôa JN: Adherence and side effects of three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad Saude Publica 2009, 25:1225-1233.
• [39]Associação Brasileira de Empresas de Pesquisa: Critério de Classificação econômica Brasil. 2010. http://www.abep.org webcite
• [40]Atalah SE, Catillo LC, Castro SR, Aldea PA: Propuesta de un nuevo estándar de evaluación nutricional de embarazadas. Rev Med Chil 1997, 125:1429-1436.
• [41]de Souza AI, Batista Filho M, Ferreira LOC, Figueirôa JN: The effectiveness of three regimens using ferrous sulfate to treat anemia in pregnant women. Rev Panam Salud Publica 2004, 15:313-319.
• [42]Mumtaz Z, Shahab S, Butt N, Abdur Rab M, De Muynck A: Daily iron supplementation is more effective than twice weekly iron supplementation in pregnant women in Pakistan in a randomized double-blind clinical trial. J Nutr 2000, 130:2697-2702.